
Gary F. Paumen
Examiner (ID: 14250, Phone: (571)272-2013 , Office: P/2833 )
| Most Active Art Unit | 2834 |
| Art Unit(s) | 2832, 0, 2833, 2899, 3202, 2834 |
| Total Applications | 7178 |
| Issued Applications | 6211 |
| Pending Applications | 288 |
| Abandoned Applications | 743 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 17429677
[patent_doc_number] => 20220057386
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-24
[patent_title] => IMMUNOFLUORESCENCE ASSAYS
[patent_app_type] => utility
[patent_app_number] => 17/222599
[patent_app_country] => US
[patent_app_date] => 2021-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5302
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17222599
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/222599 | Immunofluorescence assays | Apr 4, 2021 | Issued |
Array
(
[id] => 18676787
[patent_doc_number] => 20230314417
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-05
[patent_title] => MONOCLONAL ANTIBODIES TO CHEMICALLY-MODIFIED NUCLEIC ACIDS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/913629
[patent_app_country] => US
[patent_app_date] => 2021-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 35542
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17913629
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/913629 | MONOCLONAL ANTIBODIES TO CHEMICALLY-MODIFIED NUCLEIC ACIDS AND USES THEREOF | Mar 21, 2021 | Pending |
Array
(
[id] => 16933788
[patent_doc_number] => 20210199677
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-01
[patent_title] => SANDWICH ASSAY FOR SMALL MOLECULES
[patent_app_type] => utility
[patent_app_number] => 17/249767
[patent_app_country] => US
[patent_app_date] => 2021-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14749
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 149
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17249767
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/249767 | Sandwich assay for small molecules | Mar 11, 2021 | Issued |
Array
(
[id] => 19595206
[patent_doc_number] => 12153043
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-11-26
[patent_title] => Bi-specific probes to enable the use of single-cell samples as single color compensation control
[patent_app_type] => utility
[patent_app_number] => 17/184405
[patent_app_country] => US
[patent_app_date] => 2021-02-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 21441
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 424
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17184405
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/184405 | Bi-specific probes to enable the use of single-cell samples as single color compensation control | Feb 23, 2021 | Issued |
Array
(
[id] => 16886736
[patent_doc_number] => 20210172932
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-10
[patent_title] => IN VITRO TRANSCYTOSIS ASSAY
[patent_app_type] => utility
[patent_app_number] => 17/177414
[patent_app_country] => US
[patent_app_date] => 2021-02-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16944
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -49
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17177414
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/177414 | In vitro transcytosis assay | Feb 16, 2021 | Issued |
Array
(
[id] => 16902275
[patent_doc_number] => 20210181191
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-17
[patent_title] => ANTIGEN DETECTION USING PHOTOCLEAVABLE LABELS
[patent_app_type] => utility
[patent_app_number] => 17/174860
[patent_app_country] => US
[patent_app_date] => 2021-02-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14616
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 248
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17174860
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/174860 | ANTIGEN DETECTION USING PHOTOCLEAVABLE LABELS | Feb 11, 2021 | Abandoned |
Array
(
[id] => 18257012
[patent_doc_number] => 20230084052
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-16
[patent_title] => PROXIMITY ASSAY
[patent_app_type] => utility
[patent_app_number] => 17/798698
[patent_app_country] => US
[patent_app_date] => 2021-02-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17877
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 147
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17798698
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/798698 | PROXIMITY ASSAY | Feb 10, 2021 | Abandoned |
Array
(
[id] => 16993272
[patent_doc_number] => 20210231692
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-29
[patent_title] => METHOD FOR OBTAINING INFORMATION ON COGNITIVE FUNCTION, METHOD FOR DETERMINING EFFECTIVENESS OF MEDICAL INTERVENTION ABOUT COGNITIVE FUNCTION
[patent_app_type] => utility
[patent_app_number] => 17/154132
[patent_app_country] => US
[patent_app_date] => 2021-01-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20439
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17154132
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/154132 | METHOD FOR OBTAINING INFORMATION ON COGNITIVE FUNCTION, METHOD FOR DETERMINING EFFECTIVENESS OF MEDICAL INTERVENTION ABOUT COGNITIVE FUNCTION | Jan 20, 2021 | Abandoned |
Array
(
[id] => 20337404
[patent_doc_number] => 20250341524
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-11-06
[patent_title] => FLUORESCENTLY-LABELED F-ACTIN PROTEIN BIOSENSORS AND METHODS OF HIGH-THROUGHPUT DRUG DISCOVERY
[patent_app_type] => utility
[patent_app_number] => 17/793319
[patent_app_country] => US
[patent_app_date] => 2021-01-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10346
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17793319
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/793319 | FLUORESCENTLY-LABELED F-ACTIN PROTEIN BIOSENSORS AND METHODS OF HIGH-THROUGHPUT DRUG DISCOVERY | Jan 19, 2021 | Pending |
Array
(
[id] => 17215742
[patent_doc_number] => 20210349080
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-11
[patent_title] => MULTI-FACETED METHOD FOR DETECTING AND ANALYZING TARGET MOLECULE BY MOLECULAR APTAMER BEACON (MAB)
[patent_app_type] => utility
[patent_app_number] => 17/148630
[patent_app_country] => US
[patent_app_date] => 2021-01-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3692
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 86
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17148630
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/148630 | MULTI-FACETED METHOD FOR DETECTING AND ANALYZING TARGET MOLECULE BY MOLECULAR APTAMER BEACON (MAB) | Jan 13, 2021 | Abandoned |
Array
(
[id] => 16809506
[patent_doc_number] => 20210132060
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-06
[patent_title] => MEDICAL APPARATUS FOR TESTING FOR MEDICAL CONDITIONS INCLUDING ZIKA AND PREGNANCY
[patent_app_type] => utility
[patent_app_number] => 17/147560
[patent_app_country] => US
[patent_app_date] => 2021-01-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9418
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 124
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17147560
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/147560 | MEDICAL APPARATUS FOR TESTING FOR MEDICAL CONDITIONS INCLUDING ZIKA AND PREGNANCY | Jan 12, 2021 | Abandoned |
Array
(
[id] => 18210270
[patent_doc_number] => 20230056532
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-23
[patent_title] => METHODS FOR INFORMATION TRANSFER AND RELATED KITS
[patent_app_type] => utility
[patent_app_number] => 17/790876
[patent_app_country] => US
[patent_app_date] => 2021-01-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 45435
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17790876
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/790876 | METHODS FOR INFORMATION TRANSFER AND RELATED KITS | Jan 4, 2021 | Pending |
Array
(
[id] => 17068593
[patent_doc_number] => 20210270808
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-02
[patent_title] => METHODS OF DETERMINING INTERFERON HAVING DIRECT INHIBITORY EFFECTS ON TUMORS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/136936
[patent_app_country] => US
[patent_app_date] => 2020-12-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29156
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17136936
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/136936 | METHODS OF DETERMINING INTERFERON HAVING DIRECT INHIBITORY EFFECTS ON TUMORS AND USES THEREOF | Dec 28, 2020 | Abandoned |
Array
(
[id] => 18167794
[patent_doc_number] => 20230034402
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-02
[patent_title] => ATTACHMENT OF BIOLOGICAL AND NON-BIOLOGICAL OBJECTS
[patent_app_type] => utility
[patent_app_number] => 17/788572
[patent_app_country] => US
[patent_app_date] => 2020-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23874
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17788572
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/788572 | ATTACHMENT OF BIOLOGICAL AND NON-BIOLOGICAL OBJECTS | Dec 22, 2020 | Pending |
Array
(
[id] => 16976153
[patent_doc_number] => 20210220390
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-22
[patent_title] => PENTOSAN POLYSULFATE SODIUM FOR THE TREATMENT OF SICKLE CELL DISEASE
[patent_app_type] => utility
[patent_app_number] => 17/132885
[patent_app_country] => US
[patent_app_date] => 2020-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22659
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17132885
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/132885 | PENTOSAN POLYSULFATE SODIUM FOR THE TREATMENT OF SICKLE CELL DISEASE | Dec 22, 2020 | Abandoned |
Array
(
[id] => 18924463
[patent_doc_number] => 20240027467
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-25
[patent_title] => Nanobody Exchange Chromatography
[patent_app_type] => utility
[patent_app_number] => 17/786724
[patent_app_country] => US
[patent_app_date] => 2020-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 38753
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17786724
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/786724 | Nanobody Exchange Chromatography | Dec 17, 2020 | Pending |
Array
(
[id] => 17713500
[patent_doc_number] => 11377483
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-07-05
[patent_title] => Sandwich assay design for small molecules
[patent_app_type] => utility
[patent_app_number] => 17/247219
[patent_app_country] => US
[patent_app_date] => 2020-12-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 9
[patent_no_of_words] => 15617
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 376
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17247219
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/247219 | Sandwich assay design for small molecules | Dec 3, 2020 | Issued |
Array
(
[id] => 16689787
[patent_doc_number] => 20210072264
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-11
[patent_title] => Use of 1,25-Dihydroxyvitamin D Values in Ratio with PTH as a Prognostic Biomarker
[patent_app_type] => utility
[patent_app_number] => 17/101433
[patent_app_country] => US
[patent_app_date] => 2020-11-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11561
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 180
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17101433
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/101433 | Use of 1,25-Dihydroxyvitamin D Values in Ratio with PTH as a Prognostic Biomarker | Nov 22, 2020 | Abandoned |
Array
(
[id] => 16779379
[patent_doc_number] => 20210116457
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-22
[patent_title] => 1,1 '-[[(SUBSTITUTED ALKYL)IMINO]BIS(ALKYLENE)]BIS-FERROCENES AND THEIR USE IN I ELECTROCHEMICAL ASSAYS BY LABELLING SUBSTRATES OF INTEREST
[patent_app_type] => utility
[patent_app_number] => 17/099290
[patent_app_country] => US
[patent_app_date] => 2020-11-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11172
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17099290
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/099290 | 1,1 '-[[(substituted alkyl)imino]bis (alkylene)]bis- ferrocenes and their use in I electrochemical assays by labelling substrates of interest | Nov 15, 2020 | Issued |
Array
(
[id] => 16825665
[patent_doc_number] => 20210140958
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-13
[patent_title] => BREVETOXIN ASSAY DEVICE, SYSTEM, AND METHOD
[patent_app_type] => utility
[patent_app_number] => 17/096629
[patent_app_country] => US
[patent_app_date] => 2020-11-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7053
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -29
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17096629
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/096629 | BREVETOXIN ASSAY DEVICE, SYSTEM, AND METHOD | Nov 11, 2020 | Abandoned |